US Bancorp’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,944
| Closed | -$59K | – | 4310 |
|
|
2022
Q3 | $59K | Buy |
3,944
+139
| +4% | +$2.08K | ﹤0.01% | 2440 |
|
|
2022
Q2 | $29K | Buy |
3,805
+120
| +3% | +$915 | ﹤0.01% | 2858 |
|
|
2022
Q1 | $34K | Buy |
3,685
+2,342
| +174% | +$21.6K | ﹤0.01% | 2811 |
|
|
2021
Q4 | $9K | Sell |
1,343
-807
| -38% | -$5.41K | ﹤0.01% | 3461 |
|
|
2021
Q3 | $25K | Buy |
2,150
+164
| +8% | +$1.91K | ﹤0.01% | 3009 |
|
|
2021
Q2 | $32K | Buy |
1,986
+51
| +3% | +$822 | ﹤0.01% | 2884 |
|
|
2021
Q1 | $35K | Sell |
1,935
-249
| -11% | -$4.5K | ﹤0.01% | 2753 |
|
|
2020
Q4 | $30K | Buy |
2,184
+874
| +67% | +$12K | ﹤0.01% | 2718 |
|
|
2020
Q3 | $16K | Buy |
1,310
+1,138
| +662% | +$13.9K | ﹤0.01% | 2874 |
|
|
2020
Q2 | $3K | Buy |
172
+54
| +46% | +$942 | ﹤0.01% | 3386 |
|
|
2020
Q1 | $2K | Sell |
118
-102
| -46% | -$1.73K | ﹤0.01% | 3429 |
|
|
2019
Q4 | $5K | Sell |
220
-61
| -22% | -$1.39K | ﹤0.01% | 3244 |
|
|
2019
Q3 | $5K | Buy |
281
+124
| +79% | +$2.21K | ﹤0.01% | 3262 |
|
|
2019
Q2 | $5K | Sell |
157
-413
| -72% | -$13.2K | ﹤0.01% | 3302 |
|
|
2019
Q1 | $27K | Buy |
570
+407
| +250% | +$19.3K | ﹤0.01% | 2749 |
|
|
2018
Q4 | $6K | Sell |
163
-937
| -85% | -$34.5K | ﹤0.01% | 3181 |
|
|
2018
Q3 | $67K | Buy |
1,100
+315
| +40% | +$19.2K | ﹤0.01% | 2418 |
|
|
2018
Q2 | $53K | Sell |
785
-147
| -16% | -$9.93K | ﹤0.01% | 2554 |
|
|
2018
Q1 | $50K | Buy |
932
+168
| +22% | +$9.01K | ﹤0.01% | 2627 |
|
|
2017
Q4 | $46K | Buy |
764
+273
| +56% | +$16.4K | ﹤0.01% | 2637 |
|
|
2017
Q3 | $24K | Buy |
+491
| New | +$24K | ﹤0.01% | 2829 |
|
|
2015
Q2 | – | Sell |
-4,430
| Closed | -$139K | – | 3667 |
|
|
2015
Q1 | $139K | Sell |
4,430
-310
| -7% | -$9.73K | ﹤0.01% | 1960 |
|
|
2014
Q4 | $138K | Buy |
+4,740
| New | +$138K | ﹤0.01% | 1950 |
|